Harnessing the Power of Enzymes for Tailoring and Valorizing Lignin.

Lignin, a structural component of lignocellulosic plants, is an alternative raw material with enormous potential to replace diminishing fossil-based resources for the sustainable production of many chemicals and materials. Unfortunately, lignin's heterogeneity, low reactivity, and strong intra- and intermolecular hydrogen interactions and modifications introduced during the pulping process present significant technical challenges. However, the increasing ability to tailor lignin biosynthesis pathways by targeting enzymes and the continued discovery of more robust biocatalysts are enabling the synthesis of novel valuable products. This review summarizes how enzymes involved in lignin biosynthesis pathways and microbial enzymes are being harnessed to produce chemicals and materials and to upgrade lignin properties for the synthesis of a variety of value-added lignin industrial products.

Material-Microbe Interfaces for Solar-Driven CO2 Bioelectrosynthesis.

Sustainable production of solar-based chemicals is possible by mimicking the natural photosynthetic mechanism. To realize the full potential of solar-to-chemical production, the artificial means of photosynthesis and the biological approach should complement each other. The recently developed hybrid microbe-metal interface combines an inorganic, semiconducting light-harvester material with efficient and simple microorganisms, resulting in a novel metal-microbe interface that helps the microbes to capture energy directly from sunlight. This solar energy is then used for sustainable biosynthesis of chemicals from CO2. This review discusses various approaches to improve the electron uptake by microbes at the bioinorganic interface, especially self-photosensitized microbial systems and integrated water splitting biosynthetic systems, with emphasis on CO2 bioelectrosynthesis.

Products Components: Alcohols.

Alcohols (CnHn+2OH) are classified into primary, secondary, and tertiary alcohols, which can be branched or unbranched. They can also feature more than one OH-group (two OH-groups = diol; three OH-groups = triol). Presently, except for ethanol and sugar alcohols, they are mainly produced from fossil-based resources, such as petroleum, gas, and coal. Methanol and ethanol have the highest annual production volume accounting for 53 and 91 million tons/year, respectively. Most alcohols are used as fuels (e.g., ethanol), solvents (e.g., butanol), and chemical intermediates.This chapter gives an overview of recent research on the production of short-chain unbranched alcohols (C1-C5), focusing in particular on propanediols (1,2- and 1,3-propanediol), butanols, and butanediols (1,4- and 2,3-butanediol). It also provides a short summary on biobased higher alcohols (>C5) including branched alcohols.

Biotechnological Production of Organic Acids from Renewable Resources.

Biotechnological processes are promising alternatives to petrochemical routes for overcoming the challenges of resource depletion in the future in a sustainable way. The strategies of white biotechnology allow the utilization of inexpensive and renewable resources for the production of a broad range of bio-based compounds. Renewable resources, such as agricultural residues or residues from food production, are produced in large amounts have been shown to be promising carbon and/or nitrogen sources. This chapter focuses on the biotechnological production of lactic acid, acrylic acid, succinic acid, muconic acid, and lactobionic acid from renewable residues, these products being used as monomers for bio-based material and/or as food supplements. These five acids have high economic values and the potential to overcome the "valley of death" between laboratory/pilot scale and commercial/industrial scale. This chapter also provides an overview of the production strategies, including microbial strain development, used to convert renewable resources into value-added products.

Bioplastics.

The number of newly developed bioplastics has increased sharply in recent years and innovative polymer materials are increasingly present on the plastics market. Bioplastics are not, however, a completely new kind of material, but rather a rediscovered class of materials within the familiar group of materials known as plastics. Therefore, existing knowledge from the plastics sector can and should be transferred to bioplastics in order to further increase their performance, material diversity and market penetration.

The limits to biocatalysis: pushing the envelope.

In the period 1985 to 1995 applications of biocatalysis, driven by the need for more sustainable manufacture of chemicals and catalytic, (enantio)selective methods for the synthesis of pharmaceutical intermediates, largely involved the available hydrolases. This was followed, in the next two decades, by revolutionary developments in protein engineering and directed evolution for the optimisation of enzyme function and performance that totally changed the biocatalysis landscape. In the same period, metabolic engineering and synthetic biology revolutionised the use of whole cell biocatalysis in the synthesis of commodity chemicals by fermentation. In particular, developments in the enzymatic enantioselective synthesis of chiral alcohols and amines are highlighted. Progress in enzyme immobilisation facilitated applications under harsh industrial conditions, such as in organic solvents. The emergence of biocatalytic or chemoenzymatic cascade processes, often with co-immobilised enzymes, has enabled telescoping of multi-step processes. Discovering and inventing new biocatalytic processes, based on (meta)genomic sequencing, evolving enzyme promiscuity, chemomimetic biocatalysis, artificial metalloenzymes, and the introduction of non-canonical amino acids into proteins, are pushing back the limits of biocatalysis function. Finally, the integral role of biocatalysis in developing a biobased carbon-neutral economy is discussed.

A evolução recente da indústria farmacêutica brasileira nos limites da subordinação econômica / The recent evolution of the Brazilian pharmaceutical industry in the limits of economic subordination

Resumo Este artigo apresenta a evolução da indústria farmacêutica brasileira e da balança comercial entre 1996 e 2014 e discute possibilidades de mudanças na política industrial farmacêutica. Os pressupostos da pesquisa foram: que as possibilidades industriais para o setor estão fortemente conectadas com o cenário internacional; e que este piorou a partir dos anos 1990, tornando o país mais vulnerável. As fontes utilizadas foram a Pesquisa Industrial Anual, do Instituto Brasileiro de Geografia Estatística, e os dados da balança comercial do Sistema de Análise das Informações, do Ministério da Indústria, Comércio Exterior e Serviços. Os valores foram deflacionados e corrigidos para desconsiderar a influência da inflação. Os resultados demonstraram que há um desequilíbrio entre a evolução das indústrias farmoquímica e de medicamentos para uso humano em relação à das indústrias voltadas para medicamentos veterinários e de produtos químicos para o agronegócio. A balança comercial mostrou-se crescentemente deficitária para produtos farmacêuticos para uso humano. Os resultados corroboraram tanto a hipótese de crescente subordinação econômica quanto os pressupostos do estudo acima apontados.

Abstract This study shows the results of the development of the Brazilian Pharmaceutical Industry and trade balance between 1996 and 2014, discussing possibilities of changes in Brazilian industrial policies. The research had two assumptions: industrial possibilities are strongly connected with the international scenario, which has worsened since the 1990s, leaving the country more vulnerable. The data sources were the Annual Industrial Survey of the Brazilian Institute of Geography and Statistics and the Foreign Trade Information System from the Ministry of Industry. The values were adjusted not to consider the inflation. The results show that there was a big imbalance between the performances of the human pharmaceutical products and pharmochemical industries in regards to those focused on the production of chemicals and veterinary pharmaceutical products, in favor of these last ones. The trade balance data show a large and growing trade deficit for medicines for human use. The results corroborated the hypothesis of growing international subordination of the Brazilian pharmaceutical industry and the assumptions mentioned above.

Industrial biomanufacturing: The future of chemical production.

The current model for industrial chemical manufacturing employs large-scale megafacilities that benefit from economies of unit scale. However, this strategy faces environmental, geographical, political, and economic challenges associated with energy and manufacturing demands. We review how exploiting biological processes for manufacturing (i.e., industrial biomanufacturing) addresses these concerns while also supporting and benefiting from economies of unit number. Key to this approach is the inherent small scale and capital efficiency of bioprocesses and the ability of engineered biocatalysts to produce designer products at high carbon and energy efficiency with adjustable output, at high selectivity, and under mild process conditions. The biological conversion of single-carbon compounds represents a test bed to establish this paradigm, enabling rapid, mobile, and widespread deployment, access to remote and distributed resources, and adaptation to new and changing markets.

Tailor-made biocatalysts enzymes for the fine chemical industry in China.

The Center of Industrial Biotechnology (CIBT) was established in Huzhou for fine chemicals in 2006 and CIBT Shanghai was founded for bulk chemicals in 2008. CIBT is a non-profit organization under auspices of the Shanghai Institutes for Biological Sciences, Shanghai Branch of the Chinese Academy of Sciences (CAS) and Huzhou Municipal Government. CIBT is affiliated with the CAS, which enables it to take advantage of the rich R&D resources and support from CAS; yet CIBT operates as an independent legal entity. The goal of CIBT is to incubate industrial biotechnologies and accelerate the commercialization of these technologies with corporate partners in China.

Massive PCDD/F contamination at the Khimprom organochlorine plant in Ufa--a review and recommendations for future management.

The Khimprom plant in Ufa was one of the largest organochlorine production facilities in Russia. This paper summarises the residual pollution of the site with polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) and highlights the current and future challenges in relation to remediation of the site. Preliminary assessment of the pollution shows large-scale PCDD/F contamination at the site from half a century production of organochlorine pesticides and solvents. This contamination is affecting the city, and 2500 residents live within 3 km with a further 350,000 living within 7 km of the factory. The current PCDD/F pollution of the site and the continuing releases highlight the urgent need for further investigations, for the site to be secured and for the contamination to be remediated. The production history of the plant means that also other unintentionally POPs, mercury and chlorinated solvents need to be considered. The current regulatory framework for PCDD/F-contaminated soil and for defining hazardous waste in the Russian Federation is not appropriate for the management of PCDD/F-contaminated sites. It is therefore suggested that a science-based regulatory framework should be developed. The Russian Federation recently ratified the Stockholm Convention providing a foundation for the development of appropriate regulations and for further assessment, securing and remediation of the site. The impacts of pollution from the Khimprom plant demonstrate that the assessment and management of the organochlorine production sites should be a priority in the implementation of the Stockholm Convention by the Russian Federation and other countries.

New frontiers for encapsulation in the chemical industry.

Encapsulation of actives comprises an area of exploration undergoing rapid growth in both academic and industrial research settings. Encapsulation processes are employed as a part of product synthesis processes for improved efficiency, enhanced stability, active ingredient compatibility, increased safety, targeted delivery, and novel performance of the end product. Such technical benefits enable producers to offer products with increased formulation complexity, access new markets, differentiate products, and improve compatibility and stability, while meeting consumer demands with improved performance, reduced costs, and new actives. In this review, we highlight several emerging academic areas of encapsulation that we believe have specific relevance to industrial formulation, with a focus on three primary areas: supramolecular encapsulation, aqueous self-assembled systems, and emulsion-based capsules. The goal of this review is to help identify the major challenges facing encapsulation technology adoption in the chemical industry, bringing focus and maximizing the potential value of ongoing research efforts.

Oleochemical industry future through biotechnology.

Lipases are the most widely used class of enzymes in organic synthesis. Enzymatic processes have been implemented in a broad range of industries as they are specific, save raw materials, energy and chemicals, environmentally friendly and fast in action compared to conventional processes. The most notable benefit is the moderate process temperature and pressure with no unwanted side reactions. In the past two decades, intensive research was carried out towards enzymatic synthesis of oleochemicals. This review has a sharp focus on the current implemented enzymatic processes for producing different oleochemicals such as fatty acids, glycerin, biodiesel, biolubricant and different alkyl esters via different processes including hydrolysis, esterification, transesterification and intraesterification.

Progress and challenges in control of chemical processes.

This review covers key developments and trends in chemical process control during the past two decades. Control methodologies and related supporting technologies are covered, and recent trends in applications are also examined. After the widespread adoption of model-based techniques by industry, control interest has begun to move beyond the traditional realm of readily measured variables to include chemical compositions and particle features. However, the shift is being slowed by the shortage of accurate, reliable, and inexpensive sensing devices. Although the past two decades saw no new major theoretical or methodological advances, several important incremental improvements and extensions have been made to help the ripening of the technologies developed in the preceding two decades. Control is regaining its importance owing to society's renewed focus on energy and the maturation of various emerging technologies, but a community-wide consensus on what general problems should be solved is lacking.

New technologies reduce greenhouse gas emissions from nitrogenous fertilizer in China.

Synthetic nitrogen (N) fertilizer has played a key role in enhancing food production and keeping half of the world's population adequately fed. However, decades of N fertilizer overuse in many parts of the world have contributed to soil, water, and air pollution; reducing excessive N losses and emissions is a central environmental challenge in the 21st century. China's participation is essential to global efforts in reducing N-related greenhouse gas (GHG) emissions because China is the largest producer and consumer of fertilizer N. To evaluate the impact of China's use of N fertilizer, we quantify the carbon footprint of China's N fertilizer production and consumption chain using life cycle analysis. For every ton of N fertilizer manufactured and used, 13.5 tons of CO2-equivalent (eq) (t CO2-eq) is emitted, compared with 9.7 t CO2-eq in Europe. Emissions in China tripled from 1980 [131 terrogram (Tg) of CO2-eq (Tg CO2-eq)] to 2010 (452 Tg CO2-eq). N fertilizer-related emissions constitute about 7% of GHG emissions from the entire Chinese economy and exceed soil carbon gain resulting from N fertilizer use by several-fold. We identified potential emission reductions by comparing prevailing technologies and management practices in China with more advanced options worldwide. Mitigation opportunities include improving methane recovery during coal mining, enhancing energy efficiency in fertilizer manufacture, and minimizing N overuse in field-level crop production. We find that use of advanced technologies could cut N fertilizer-related emissions by 20-63%, amounting to 102-357 Tg CO2-eq annually. Such reduction would decrease China's total GHG emissions by 2-6%, which is significant on a global scale.

Commercial proteases: present and future.

This review presents a brief overview of the general categories of commercially used proteases, and critically surveys the successful strategies currently being used to improve the properties of proteases for various commercial purposes. We describe the broad application of proteases in laundry detergents, food processing, and the leather industry. The review also introduces the expanding development of proteases as a class of therapeutic agents, as well as highlighting recent progress in the field of protease engineering. The potential commercial applications of proteases are rapidly growing as recent technological advances are producing proteases with novel properties and substrate specificities.